Diagnosis and Management of Adverse Drug Reactions in Precision Medicine and Big Data
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 39
Special Issue Editor
Interests: clinical pharmacology; drug safety; adverse drug events; adverse drug reactions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to provide a comprehensive and up-to-date collection of research on the multifaceted aspects of adverse drug reactions (ADRs). We will explore innovative approaches in ADR detection, causality assessment, risk factors identification, pharmacogenomics of ADRs, and strategies for prevention and management. Recognizing the evolving landscape of pharmacovigilance, we also encourage submissions that delve into the role of artificial intelligence, big data analytics, and patient-reported outcomes in enhancing our understanding and mitigation of ADRs. Furthermore, we welcome studies focusing on specific populations, drug classes, and novel therapeutic agents, as well as research addressing the economic and public health impact of ADRs.
We look forward to your submissions.
Dr. Elena Ramírez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adverse drug reactions
- pharmacovigilance
- drug safety
- risk factors
- causality assessment
- big data
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
